Results 191 to 200 of about 398,598 (315)

Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy. [PDF]

Int J Mol Sci, 2022
Ortega Á, Salazar J, Galban N, Rojas M, Ariza D, Chávez-Castillo M, Nava M, Riaño-Garzón ME, Díaz-Camargo EA, Medina-Ortiz O, Bermúdez V.   +10 more
europepmc   +1 more source

Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective We used data from the placebo arm of the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial to determine the prognostic/predictive significance of peripheral blood cell (PBC) transcript modules for the course of forced vital capacity (FVC) in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD ...
Shervin Assassi, Christopher P. Denton, Matthias Zwick, Ramona Schmid, Carina Ittrich, Tobias Litzenburger, Sudha Visvanathan   +6 more
wiley   +1 more source

Caffeine Placebo Effect in Sport and Exercise: A Systematic Review. [PDF]

Nutrients
Vega-Muñoz A, Contreras-Barraza N, Salazar-Sepúlveda G, Lay N, Gil-Marín M, Muñoz-Urtubia N.   +5 more
europepmc   +1 more source

[What can psychotherapy learn from the placebo effect?] [PDF]

Psychotherapeut (Berl), 2022
Rief W.
europepmc   +1 more source

Efficacy and Safety of ABBV‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial

Arthritis &Rheumatology, EarlyView.
Objective Despite the availability of biologic and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit, Atul Singhal, Alan Kivitz, Edit Drescher, Yoshinori Taniguchi, Rosalía Martínez Pérez, Jaclyn Anderson, Ronilda D'Cunha, Weihan Zhao, Nicholas DeVogel, Julie Parmentier, Romy Christmann, Dilek Arikan, Howard Amital   +13 more
wiley   +1 more source

Premovement activity in the corticospinal tract is amplified by the placebo effect: an active inference account. [PDF]

Soc Cogn Affect Neurosci
Emadi Andani M, Braga M, Da Dalt F, Piedimonte A, Carlino E, Fiorio M.   +5 more
europepmc   +1 more source

Intra-articular placebo effect in the treatment of knee osteoarthritis: a survey of the current clinical evidence. [PDF]

Ther Adv Musculoskelet Dis, 2022
Fazeli MS, McIntyre L, Huang Y, Chevalier X.   +3 more
europepmc   +1 more source

A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: Effect on inflammation, psychopathology, cognition and lipid metabolism

, 2014
Brenda Vincenzi, Shannon Stock, Christina P. C. Borba, Sarah Cleary, Claire E. Oppenheim, Liana Petruzzi, Xiaoduo Fan, Paul M. Copeland, Oliver Freudenreich, Corinne Cather, David C. Henderson   +10 more
openalex   +1 more source

Pharmacodynamic Effects of Litifilimab in Lupus in a Randomized, Placebo‐Controlled Phase 2 Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines

Arthritis &Rheumatology, EarlyView.
Objective The pharmacodynamic effects of litifilimab on type I interferon (IFN) response and correlations with clinical outcomes were investigated in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Methods Participants from part A (SLE) or part B (CLE with or without SLE) of the randomized phase 2 LILAC trial who received ...
Richard Furie, Victoria P. Werth, Eric Milliman, Kyle Ferber, Roland Brown, Jad Zoghbi, Nathalie Franchimont, Youmna Lahoud, Catherine Barbey   +8 more
wiley   +1 more source